Clinical Trials Directory

Trials / Completed

CompletedNCT06572007

The Impact Of Fascia Thickness on Chronic Low Back Pain

Relationships of Fascia Thickness With Pain, Flexibility, Disability and Depression in Individuals With Chronic Low Back Pain

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Okan University · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers

Summary

This study aimed to investigate the impact of lumbar perimuscular and subcutaneous zone thickness on pain, functionality, disability, and depression in individuals with chronic low back pain (CLBP).

Detailed description

This study investigates the role of the thoracolumbar fascia (TLF) in chronic low back pain (CLBP) persisting for more than one year. Specifically, the researchers aim to examine the relationships between various factors in individuals with CLBP, including the thickness of the perimuscular and subcutaneous regions in the lumbar and hamstring regions. The relationship with functional tests of the lower back and lower limbs will also be analysed. In addition, the intensity of the pain experienced by the participants, the extent to which the pain restricts their daily activities, and depression scores will be assessed. Through this analysis, the researchers aim to gain a deeper understanding of TLF's involvement in CLBP and its impact on the overall well-being of affected individuals.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasoundTo investigate the thickness of the fascia tissue, the subjects will undergo an ultrasound examination using a clinical ultrasound system (S9, SonoScape Corporation, made in China) with a linear 5-14 MHz array of L14-5/38. The transducer with a cross-section of 6.24 cm2 will be aimed at points 2 cm lateral to the midline of the L2 and L3 vertebrae on both sides of the spine.

Timeline

Start date
2024-09-15
Primary completion
2024-10-25
Completion
2024-10-25
First posted
2024-08-26
Last updated
2024-10-29

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06572007. Inclusion in this directory is not an endorsement.